Publications by authors named "Deborah Clarke"

Claim this Profile
E
Effect of tezepelumab on asthma exacerbations co-occurring with infection-attributed acute respiratory illnesses.
Wojciech Feleszko, Marco Caminati, James E Gern, Sebastian L Johnston, Claudio Marchese, Deborah Clarke

Ann Allergy Asthma Immunol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 vaccination antibody responses in patients with aplastic anaemia and paroxysmal nocturnal haemoglobinuria.
Alexandra Pike, Claire McKinley, Briony Forrest, Rebecca Scott, Emily Charlton, Deborah Clarke

Lancet Haematol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coprocytobiology: A Technical Review of Cytological Colorectal Cancer Screening in Fecal Samples.
Liam Ryan, YenTing Wong, Karen M Dwyer, Deborah Clarke, Lynda Kyprian

SLAS Technol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient Reported Experiences and Delays During the Diagnostic Pathway for Pulmonary Fibrosis: A Multinational European Survey.
Iris G van der Sar, Steve Jones, Deborah L Clarke, Francesco Bonella, Jean Michel Fourrier

Front Med (Lausanne)· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rhinovirus-induced CCL17 and CCL22 in Asthma Exacerbations and Differential Regulation by STAT6.
Teresa C Williams, David J Jackson, Steven Maltby, Ross P Walton, Yee-Mann Ching, Deborah Clarke

Am J Respir Cell Mol Biol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of mast cells: a novel mechanism by which nintedanib may elicit anti-fibrotic effects.
Catherine Overed-Sayer, Elena Miranda, Rebecca Dunmore, Elena Liarte Marin, Lorea Beloki, Deborah Clarke

Thorax· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients with paroxysmal nocturnal hemoglobinuria demonstrate a prothrombotic clotting phenotype which is improved by complement inhibition with eculizumab.
Fraser L Macrae, Barnaby Peacock-Young, Polly Bowman, Stephen R Baker, Sam Quested, Deborah Clarke

Am J Hematol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distal lung epithelial progenitor cell function declines with age.
Julie K Watson, Philip Sanders, Rebecca Dunmore, Guglielmo Rosignoli, Yvon Julé, Deborah Clarke

Sci Rep· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Healthcare Resource Utilization Among Patients in England with Systemic Sclerosis-Associated Interstitial Lung Disease: A Retrospective Database Analysis.
Alicia Gayle, Nils Schoof, Margarida Alves, Deborah Clarke, Christina Raabe

Adv Ther· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long Non-coding RNAs Are Central Regulators of the IL-1β-Induced Inflammatory Response in Normal and Idiopathic Pulmonary Lung Fibroblasts.
Marina R Hadjicharalambous, Benoit T Roux, Carol A Feghali-Bostwick, Lynne A Murray, Deborah L Clarke

Front Immunol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sleep characteristics, sources of perceived stress and coping strategies in adolescent athletes.
Melissa Skein, Tristan Harrison, Deborah Clarke

J Sleep Res· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long intergenic non-coding RNAs regulate human lung fibroblast function: Implications for idiopathic pulmonary fibrosis.
Marina R Hadjicharalambous, Benoit T Roux, Eszter Csomor, Carol A Feghali-Bostwick, Lynne A Murray, Deborah L Clarke

Sci Rep· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is personalised medicine the key to heterogeneity in idiopathic pulmonary fibrosis?
Deborah L Clarke, Lynne A Murray, Bruno Crestani, Matthew A Sleeman

Pharmacol Ther· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are mast cells instrumental for fibrotic diseases?
Catherine Overed-Sayer, Laura Rapley, Tomas Mustelin, Deborah L Clarke

Front Pharmacol· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A crucial role for the ubiquitously expressed transcription factor Sp1 at early stages of hematopoietic specification.
Jane Gilmour, Salam A Assi, Ulrike Jaegle, Divine Kulu, Harmen van de Werken, Deborah Clarke

Development· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a mouse model mimicking key aspects of a viral asthma exacerbation.
Deborah L Clarke, Nicola H E Davis, Jayesh B Majithiya, Sian C Piper, Arthur Lewis

Clin Sci (Lond)· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The epithelium in idiopathic pulmonary fibrosis: breaking the barrier.
Ana Camelo, Rebecca Dunmore, Matthew A Sleeman, Deborah L Clarke

Front Pharmacol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Matrix regulation of idiopathic pulmonary fibrosis: the role of enzymes.
Deborah L Clarke, Alan M Carruthers, Tomas Mustelin, Lynne A Murray

Fibrogenesis Tissue Repair· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engineering approaches to develop the next generation of antibodies to respiratory targets.
Katherine A Vousden, Deborah L Clarke, David C Lowe

Inflamm Allergy Drug Targets· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defining critical roles for NF-κB p65 and type I interferon in innate immunity to rhinovirus.
Nathan W Bartlett, Louise Slater, Nicholas Glanville, Jennifer J Haas, Gaetano Caramori, Deborah L Clarke

EMBO Mol Med· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RUNX1 reshapes the epigenetic landscape at the onset of haematopoiesis.
Monika Lichtinger, Richard Ingram, Rebecca Hannah, Dorothee Müller, Deborah Clarke

EMBO J· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EP4 receptor as a new target for bronchodilator therapy.
James Buckley, Mark A Birrell, Sarah A Maher, Anthony T Nials, Deborah L Clarke

Thorax· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential regulation of sense and antisense promoter activity at the Csf1R locus in B cells by the transcription factor PAX5.
Richard M Ingram, Stephanie Valeaux, Nicola Wilson, M Amine Bouhlel, Deborah Clarke

Exp Hematol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Co-ordinated role of TLR3, RIG-I and MDA5 in the innate response to rhinovirus in bronchial epithelium.
Louise Slater, Nathan W Bartlett, Jennifer J Haas, Jie Zhu, Simon D Message, Deborah L Clarke

PLoS Pathog· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis